Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synovial fluid viscoelasticity refers to the rheological behavior of the fluid within diarthrodial joints, characterized by its ability to act as both a viscous lubricant and an elastic shock absorber. This dual functionality is primarily mediated by high-molecular-weight hyaluronic acid (HA) and the glycoprotein lubricin, which are secreted by synoviocytes and chondrocytes (StatPearls, 2023). Under low-frequency strain, the fluid behaves like a viscous liquid to reduce friction during slow movement; under high-frequency strain, it behaves like an elastic solid to protect the articular cartilage from mechanical impact (PubMed, 2021). In pathological conditions such as osteoarthritis, the concentration and average molecular weight of HA are significantly diminished due to dilution by effusion and degradation by reactive oxygen species and enzymes (NIH, 2022). This loss of viscoelasticity results in increased mechanical wear on the joint surfaces and contributes to the cycle of inflammation and pain (PubMed, 2020). Therapeutic strategies known as viscosupplementation involve the intra-articular injection of exogenous HA derivatives to temporarily restore the fluid's rheological properties and stimulate endogenous HA production (Arthritis Foundation, 2023). While not a single molecular target, the restoration of synovial fluid viscoelasticity is a primary goal in the non-surgical management of joint degeneration.
Viscosupplementation (restoration of rheological properties and lubrication through intra-articular injection of high-molecular-weight hyaluronic acid)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synovial fluid viscoelasticity.